Healthcare -
Biotechnology - NASDAQ - FR
$ 1.8355
-2.53 %
$ 154 M
Market Cap
-2.76
P/E
IPHA - LONG-TERM DEBT
Long-term Debt IPHA - Innate Pharma S.A.
31 M
LAST VALUE
51.41%
2 YEAR CAGR
57.69%
5 YEAR CAGR
22.09%
10 YEAR CAGR